Assessment of the immunogenicity and safety of the Northern Hemisphere 2010/2011-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations: an open label, non-randomised uncontrolled safety and efficacy study.

Trial Profile

Assessment of the immunogenicity and safety of the Northern Hemisphere 2010/2011-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations: an open label, non-randomised uncontrolled safety and efficacy study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza A virus infections
  • Focus Pharmacodynamics
  • Sponsors Crucell
  • Most Recent Events

    • 03 Mar 2011 New source identified and integrated (Clinicaltrials.gov, NCT01306305).
    • 02 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top